Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Oct 14;13:2003–2015. doi: 10.2147/OPTH.S215144

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2019 Ong et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

Refractive outcomes of eyes that underwent SMILE procedures. (A) Cumulative percentage of eyes in which the target refraction was zero that attained the specified levels of uncorrected distance visual acuity (UDVA) 3 months after surgery. CDVA = corrected distance visual acuity; (B) cumulative percentage of eyes in which the target refraction was zero that attained the specified levels of UDVA 3 years after surgery; (C) percentage of eyes with post-operative spherical equivalent refractions within intended target spherical equivalent refraction; (D) scatter plot and linear regression analysis of the attempted spherical equivalent refractive change versus the achieved spherical equivalent refractive change at 3 months after surgery; (E) stability of post-operative spherical equivalent at 3 years after surgery; (F) percentage of eyes in which there was a gain or loss of lines in CDVA 3 months and 3 years after surgery.